Abesamis, Lilia D.
HRN: 01-19-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
CEFIXIME 200MG (CAP)
01/10/2023
01/17/2023
ORAL
200 Mg
BID
CAP MR, Resolving
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes